National Comprehensive Cancer Network Guideline Updates From the 15th Annual Congress
Author Disclosure: Anthony Elias, MD, discloses that he has received grants for clinical trials from Pfizer and Roche.
Planning Committee Disclosures: Independent medical writer William Yarnall, RPh, CCP, and the staff of Pharmacy Times Office of Continuing Professional education and The American Journal of Pharmacy Benefits have nothing to disclose relative to this activity.
Educational Objectives
After completing this activity, participants should be able to:
• List some of the major National Comprehensive Cancer Network (NCCN) practice guideline revisions presented at the 15th Annual Congress
• Identify select NCCN guideline revisions that may impact the course of treatment in a given case
• Discuss the use of patient characteristics to determine therapeutic management in select NCCN guideline revisions
Target Audience: Pharmacy directors/administrators, clinical pharmacists practicing in managed care environments, and any other pharmacist practitioners involved in the care of patients diagnosed with cancer
Type of Activity: Knowledge
Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This program is approved for 1.0 contact hours (0.10 CEUs) under the ACPE universal program number 0290-0000-10-013-H04-P. The program is available for CE credit through June 15, 2012.
INSTRUCTIONS FOR CREDIT
There is no fee for this activity. To receive credit, participant must read the CE activity in its entirety and complete the post-test and evaluation form. Each participant achieving a passing grade of 70% or better will receive a statement of credit giving the number of CE credits earned. If you do not achieve a score of 70% or better on the post-test, you will have the opportunity take the post-test one more time at no cost.
The post-test and evaluation can be completed online. Please visit www.ajpblive.com/ce, where you will be provided with a link to the lesson, post-test, and evaluation. You will have the opportunity to print the post-test questions and evaluation and manually complete ahead of time and submit answers online at your convenience.
Please retain a copy of the certificate for your records. For questions, please e-mail ceinfo@pharmacytimes.com
Educational Disclaimer
Continuing professional education (CPE) activities sponsored by Pharmacy Times Office of CPE are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
The author(s), reviewer(s), and editor(s) have made extensive efforts to ensure that the information including treatments, drugs, and dosage regimens are accurate and conform to the standards accepted at the time of publication. However, healthcare professionals should always consult additional sources of information and exercise their best professional judgment before making clinical decisions of any kind. In particular, the reader is advised to check the product information provided by the manufacturer of a drug product before prescribing or administering it, especially if the drug is unfamiliar or is used infrequently.
Planning Committee Disclosures: Independent medical writer William Yarnall, RPh, CCP, and the staff of Pharmacy Times Office of Continuing Professional education and The American Journal of Pharmacy Benefits have nothing to disclose relative to this activity.
Educational Objectives
After completing this activity, participants should be able to:
• List some of the major National Comprehensive Cancer Network (NCCN) practice guideline revisions presented at the 15th Annual Congress
• Identify select NCCN guideline revisions that may impact the course of treatment in a given case
• Discuss the use of patient characteristics to determine therapeutic management in select NCCN guideline revisions
Target Audience: Pharmacy directors/administrators, clinical pharmacists practicing in managed care environments, and any other pharmacist practitioners involved in the care of patients diagnosed with cancer
Type of Activity: Knowledge
Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This program is approved for 1.0 contact hours (0.10 CEUs) under the ACPE universal program number 0290-0000-10-013-H04-P. The program is available for CE credit through June 15, 2012.
INSTRUCTIONS FOR CREDIT
There is no fee for this activity. To receive credit, participant must read the CE activity in its entirety and complete the post-test and evaluation form. Each participant achieving a passing grade of 70% or better will receive a statement of credit giving the number of CE credits earned. If you do not achieve a score of 70% or better on the post-test, you will have the opportunity take the post-test one more time at no cost.
The post-test and evaluation can be completed online. Please visit www.ajpblive.com/ce, where you will be provided with a link to the lesson, post-test, and evaluation. You will have the opportunity to print the post-test questions and evaluation and manually complete ahead of time and submit answers online at your convenience.
Please retain a copy of the certificate for your records. For questions, please e-mail ceinfo@pharmacytimes.com
Educational Disclaimer
Continuing professional education (CPE) activities sponsored by Pharmacy Times Office of CPE are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
The author(s), reviewer(s), and editor(s) have made extensive efforts to ensure that the information including treatments, drugs, and dosage regimens are accurate and conform to the standards accepted at the time of publication. However, healthcare professionals should always consult additional sources of information and exercise their best professional judgment before making clinical decisions of any kind. In particular, the reader is advised to check the product information provided by the manufacturer of a drug product before prescribing or administering it, especially if the drug is unfamiliar or is used infrequently.
In order to serve our readers better, please provide your information and become a member of our Web site. Membership is FREE.
Advertisement





